Rubius Therapeutics   Report issue

For profit Phase 1 Phase 2
Founded: Cambridge MA United States (2014)

Organization Overview

First Clinical Trial
2019
NCT04110496
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Rubius Therapeutics